2 research outputs found
Switch of Surface Adhesion to Cohesion by Dopa-Fe<sup>3+</sup> Complexation, in Response to Microenvironment at the Mussel Plaque/Substrate Interface
Although
Dopa-Fe<sup>3+</sup> complexation is known to play an
important role in mussel adhesion for providing mechanical properties,
its function at the plaque/substrate interface, where actual surface
adhesion occurs, remains unknown, with regard to interfacial mussel
adhesive proteins (MAPs) type 3 fast variant (fp-3F) and type 5 (fp-5).
Here, we confirmed Dopa-Fe<sup>3+</sup> complexation of interfacial
MAPs and investigated the effects of Dopa-Fe<sup>3+</sup> complexation
regarding both surface adhesion and cohesion. The force measurements
using surface forces apparatus (SFA) analysis showed that intrinsic
strong surface adhesion at low pH, which is similar to the local acidified
environment present during the secretion of adhesive proteins, vanishes
by Dopa-Fe<sup>3+</sup> complexation and alternatively, strong cohesion
is generated in higher pH conditions similar to seawater. A high Dopa
content increased the capacity for both surface adhesion and cohesion,
but not at the same time. In contrast, a lack of Dopa resulted in
both weak surface adhesion and cohesion without significant effects
of Fe<sup>3+</sup> complexation. Our findings shed light on how mussels
regulate Dopa functionality at the plaque/substrate interface, in
response to the microenvironment, and might provide new insight for
the design of mussel-inspired biomaterials
Sprayable Adhesive Nanotherapeutics: Mussel-Protein-Based Nanoparticles for Highly Efficient Locoregional Cancer Therapy
Following
surgical resection for primary treatment of solid tumors,
systemic chemotherapy is commonly used to eliminate residual cancer
cells to prevent tumor recurrence. However, its clinical outcome is
often limited due to insufficient local accumulation and the systemic
toxicity of anticancer drugs. Here, we propose a sprayable adhesive
nanoparticle (NP)-based drug delivery system using a bioengineered
mussel adhesive protein (MAP) for effective locoregional cancer therapy.
The MAP NPs could be administered to target surfaces in a surface-independent
manner through a simple and easy spray process by virtue of their
unique adhesion ability and sufficient dispersion property. Doxorubicin
(DOX)-loaded MAP NPs (MAP@DOX NPs) exhibited efficient cellular uptake,
endolysosomal trafficking, and subsequent low pH microenvironment-induced
DOX release in cancer cells. The locally sprayed MAP@DOX NPs showed
a significant inhibition of tumor growth <i>in vivo</i>,
resulting from the prolonged retention of the MAP@DOX NPs on the tumor
surface. Thus, this adhesive MAP NP-based spray therapeutic system
provides a promising approach for topical drug delivery in adjuvant
cancer therapy